Table 10.
Attributes | T01) | T1 | T2 | Period (mean±SE) | p value2) | ||
---|---|---|---|---|---|---|---|
| |||||||
P | T | T×P | |||||
Antibody titre (log2 basis) | |||||||
0 d | 2.04±0.18 | 2.74±0.30 | 2.28±0.44 | 2.36±0.18B | <0.001 | 0.074 | 0.995 |
7 d | 3.69±0.45 | 3.88±0.42 | 3.93±0.57 | 3.83±0.26AB | |||
14 d | 4.08±0.36 | 4.08±0.36 | 4.09±0.45 | 4.08±0.21A | |||
21 d | 3.88±0.42 | 4.08±0.36 | 3.86±0.51 | 3.94±0.23AB | |||
28 d | 3.60±0.24 | 3.88±0.42 | 3.76±0.23 | 3.75±0.17AB | |||
Treatment (mean±SE) | 3.46±0.19 | 3.73±0.18 | 3.58±0.23 |
RBC, red blood cell; SE, standard error.
T0, control group; T1, tea seed supplemented group; T2, tea saponin supplemented group.
T, treatment; P, period; T×P, interaction.
Means bearing different superscripts (A and B) in a column differ significantly.